Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - CA
$ 2.345
-8.04 %
$ 4.69 M
Market Cap
-0.02
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
315.06%
EBIT
Estimate
--1640.72%
Net Income
Estimate
103.24%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Sunshine Biopharma, Inc.
SBFM has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart SBFM
EBIT FORECAST
EBIT Forecast Chart SBFM
NET INCOME FORECAST
Net Income Chart SBFM